Ultrastructural distribution of PMP22 in Charcot-Marie-Tooth disease type 1A

被引:50
|
作者
Haney, C
Snipes, GJ
Shooter, EM
Suter, U
Garcia, C
Griffin, JW
Trapp, BD
机构
[1] CLEVELAND CLIN FDN, DEPT NEUROSCI, CLEVELAND, OH 44195 USA
[2] STANFORD UNIV, SCH MED, DEPT NEUROBIOL, STANFORD, CA 94305 USA
[3] STANFORD UNIV, SCH MED, DEPT NEUROPATHOL, STANFORD, CA 94305 USA
[4] SWISS FED INST TECHNOL, ETH HONGGERBERG, DEPT CELL BIOL, CH-8093 ZURICH, SWITZERLAND
[5] LOUISIANA STATE UNIV, MED CTR, SCH MED, DEPT NEUROL, NEW ORLEANS, LA 70112 USA
[6] LOUISIANA STATE UNIV, MED CTR, SCH MED, DEPT PATHOL, NEW ORLEANS, LA 70112 USA
[7] JOHNS HOPKINS UNIV, SCH MED, DEPT NEUROL, NEUROMUSCULAR DIV, BALTIMORE, MD 21287 USA
关键词
D O I
10.1097/00005072-199603000-00004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Peripheral Myelin Protein-22 (PMP22) is a membrane glycoprotein which represents up to 5% of total protein in myelin of peripheral nerves. Mutations affecting the PMP22 gene have been linked to the inherited peripheral neuropathies Charcot-Marie-Tooth disease type 1A (CMT1A; duplications and point mutations), Dejerine-Sottas syndrome (DSS; point mutations), and hereditary neuropathy with liability to pressure palsies (HNPP; deletions). In this study, we determined the ultrastructural distribution of PMP22 and other myelin proteins in normal human peripheral nervous system (PNS) nerves and in CMT1 patients with or without the CMT1A duplication on chromosome 17. Our results demonstrate that PMP22, P-0 protein, and myelin basic protein are present in compact myelin of all patients examined. PMP22 was also present in the plasma membrane of Schwann cells of unmyelinated fibers and onion bulbs. Although the precise biological role of PMP22 remains to be discovered, our results support the hypothesis that this protein serves multiple functions in Schwann cells.
引用
收藏
页码:290 / 299
页数:10
相关论文
共 50 条
  • [1] Distal enhancers upstream of the Charcot-Marie-Tooth type 1A disease gene PMP22
    Jones, Erin A.
    Brewer, Megan H.
    Srinivasan, Rajini
    Krueger, Courtney
    Sun, Guannan
    Charney, Kira N.
    Keles, Sunduz
    Antonellis, Anthony
    Svaren, John
    HUMAN MOLECULAR GENETICS, 2012, 21 (07) : 1581 - 1591
  • [2] Squalenoyl siRNA PMP22 nanoparticles, a potent therapy for Charcot-Marie-Tooth disease type 1A
    Boutary, Suzan
    Massaad-Massade, Liliane
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2021, 26 (03) : 363 - 364
  • [3] SNP analysis of PMP22 and predicted PMP22 targeting mir genes in Charcot-Marie-Tooth neuropathy type 1A
    Nam, S. H.
    Lee, H. J.
    Shin, B. L.
    Choi, B. O.
    Chung, K. W.
    MOLECULAR BIOLOGY OF THE CELL, 2013, 24
  • [4] Severe phenotypes in a Charcot-Marie-Tooth 1A patient with PMP22 triplication
    Kim, Sung Min
    Lee, Jinho
    Yoon, Bo Ram
    Kim, Ye Jin
    Choi, Byung-Ok
    Chung, Ki Wha
    JOURNAL OF HUMAN GENETICS, 2015, 60 (02) : 103 - 106
  • [5] PMP22 antisense oligonucleotides reverse Charcot-Marie-Tooth disease type 1A features in rodent models
    Zhao, Hien Tran
    Damle, Sagar
    Ikeda-Lee, Karli
    Kuntz, Steven
    Li, Jian
    Mohan, Apoorva
    Kim, Aneeza
    Hung, Gene
    Scheideler, Mark A.
    Scherer, Steven S.
    Svaren, John
    Swayze, Eric E.
    Kordasiewicz, Holly B.
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (01): : 359 - 368
  • [6] Left ventricular hypertrabeculation/noncompaction with PMP22 duplication-based Charcot-Marie-Tooth disease type 1A
    Corrado, Giovanni
    Checcarelli, Nicoletta
    Santarone, Mauro
    Stoellberger, Claudia
    Finsterer, Josef
    CARDIOLOGY, 2006, 105 (03) : 142 - 145
  • [7] PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with liability to Pressure Palsies
    van Paassen, Barbara W.
    van der Kooi, Anneke J.
    van Spaendonck-Zwarts, Karin Y.
    Verhamme, Camiel
    Baas, Frank
    de Visser, Marianne
    ORPHANET JOURNAL OF RARE DISEASES, 2014, 9
  • [8] PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with liability to Pressure Palsies
    Barbara W van Paassen
    Anneke J van der Kooi
    Karin Y van Spaendonck-Zwarts
    Camiel Verhamme
    Frank Baas
    Marianne de Visser
    Orphanet Journal of Rare Diseases, 9
  • [9] Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease
    Nobbio, L
    Vigo, T
    Abbruzzese, M
    Levi, G
    Brancolini, C
    Mantero, S
    Grandis, M
    Benedetti, L
    Mancardi, G
    Schenone, A
    NEUROBIOLOGY OF DISEASE, 2004, 16 (01) : 263 - 273
  • [10] EVIDENCE FOR A RECESSIVE PMP22 POINT MUTATION IN CHARCOT-MARIE-TOOTH DISEASE TYPE-1A
    ROA, BB
    GARCIA, CA
    LIU, PT
    KILLIAN, JM
    TRASK, BJ
    SUTER, U
    SNIPES, GJ
    ORTIZLOPEZ, R
    SHOOTER, EM
    PATEL, PI
    LUPSKI, JR
    NATURE GENETICS, 1993, 5 (02) : 189 - 194